Skip to main content
Neurology

<![CDATA[Pediatric MOGAD: Phenotype-Driven Presentation, Steroid Responsiveness, and Relapse-Guided Management]]>

Post Content: Source: Neurology Read More
Neurology

<![CDATA[FDA Clears Cala kIQ Plus for Essential Tremor and Parkinson Disease Hand Tremor]]>

Post Content: Source: Neurology Read More
Neurology

<![CDATA[Emerging Therapies for Pompe Disease: What the Latest Literature Means for Neurologists]]>

Post Content: Source: Neurology Read More
Neurology
<![CDATA[The Evolution of Pompe disease From Fatal Infantile Disorder to Treatable Myopathy]]>
Neurology
<![CDATA[Steroid Transitions: Clinical Decision-Making Across the DMD Disease Course]]>
Neurology
<![CDATA[Optimizing Narcolepsy Treatment Through Polypharmacy]]>
Neurology
<![CDATA[NeuroVoices: Yasha Kayan, MD, on Stroke, Devices, and Emerging Therapies for Neurointervention]]>
Neurology
<![CDATA[Elecsys NfL Test Receives European Approval for Monitoring Neuroinflammation in Relapsing-Remitting Multiple Sclerosis]]>
Neurology
<![CDATA[Severe NMOSD Disability Associated With Escalation to Rituximab, Study Shows]]>
admin
By In Pyschiatry

What APA Is Doing for You: Update on Clozapine REMS

In November 2021, the Food and Drug Administration (FDA) instituted a new Clozapine Risk Evaluation and Mitigation Strategy (REMS) to…
Read More
Visit Our Podcast

Oncology Overdrive